LAB — STANDARD BIOTOOLS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying LAB?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
No tracked investor changed their LAB position last quarter. Macro conditions are mixed for this sector (Macro Tailwind 46/100 in a Overheat regime).
- +4 tracked investors reported holding LAB at their latest filing
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 10/21/2026.
About STANDARD BIOTOOLS INC (LAB)
STANDARD BIOTOOLS INC (LAB) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Andreas Halvorsen (Viking Global Investors), valued at $113M. Across recent filings, tracked investors recorded 2 new positions, 2 increased, 4 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in LAB
How many top investors track LAB
A small number of top investors own this.
LAB Ownership Composition
How STANDARD BIOTOOLS INC is held across tracked investor types, based on reported 13F positions.
- Other89.9%
- Multi-Strategy / Quant10.1%
Tracked investors currently reporting LAB
1 tracked investor has since exited this position — listed separately below.
- Andreas HalvorsenJun 30, 2026Viking Global InvestorsShares58.7MValue$48.3M% Portfolio0.14%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares3.5MValue$2.9M% Portfolio0.00%
- Ken GriffinJun 30, 2026Citadel AdvisorsShares2.4MValue$2M% Portfolio0.00%
- Steve CohenJun 30, 2026Point72 Asset ManagementShares708KValue$582.5K% Portfolio0.00%
Previously held LAB
These investors reported LAB in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Cathie Wood | ARK Investment Management | 3.1M | $3.9M | Dec 31, 2025 |
Recent activity
- Unchanged$102.6M(0.00%)Feb 14, 2025
- Unchanged$63.3M(0.00%)May 15, 2025
- Unchanged$70.4M(0.00%)Aug 14, 2025
- Unchanged$76.2M(0.00%)Nov 14, 2025
- Unchanged$75.1M(0.00%)Feb 17, 2026
- Unchanged$53.9M(0.00%)May 15, 2026
- Unchanged$48.3M(0.00%)Aug 14, 2026
- New$35.3MApr 18, 2024
- Reduced$22.4M(-2.78%)Jul 26, 2024
- Reduced$17.3M(-29.41%)Oct 31, 2024
- Reduced$5.8M(-62.86%)Feb 4, 2025
- Increased$3.7M(3.89%)May 7, 2025
- Reduced$3.8M(-8.63%)Jul 30, 2025
- Increased$3.9M(1.49%)Feb 11, 2026
- Sold$0(-100.00%)May 12, 2026
- $113.2MNov 14, 2024
Frequently asked questions
- How many institutional investors hold LAB?
- 4 tracked institutional investors disclosed a position in LAB (STANDARD BIOTOOLS INC) in their most recent 13F filing.
- Who is the largest institutional holder of LAB?
- Andreas Halvorsen, Viking Global Investors, holds the largest disclosed position in LAB, valued at $113M.
- Did institutional ownership of LAB increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 2 increased, 4 reduced, and 1 fully exited LAB.
- Where does this LAB ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.